These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30040737)

  • 1. Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders.
    Anderson KE; van Duijn E; Craufurd D; Drazinic C; Edmondson M; Goodman N; van Kammen D; Loy C; Priller J; Goodman LV
    J Huntingtons Dis; 2018; 7(3):355-366. PubMed ID: 30040737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expert consensus guideline series. Treatment of behavioral emergencies 2005.
    Allen MH; Currier GW; Carpenter D; Ross RW; Docherty JP;
    J Psychiatr Pract; 2005 Nov; 11 Suppl 1():5-108; quiz 110-2. PubMed ID: 16319571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
    van Duijn E; Craufurd D; Hubers AA; Giltay EJ; Bonelli R; Rickards H; Anderson KE; van Walsem MR; van der Mast RC; Orth M; Landwehrmeyer GB;
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1411-8. PubMed ID: 24828898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmotor Symptoms in Huntington Disease.
    Cardoso F
    Int Rev Neurobiol; 2017; 134():1397-1408. PubMed ID: 28805577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and management of behavioral and psychological symptoms of dementia.
    Kales HC; Gitlin LN; Lyketsos CG
    BMJ; 2015 Mar; 350():h369. PubMed ID: 25731881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.
    Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J
    Parkinsonism Relat Disord; 2016 Apr; 25():58-64. PubMed ID: 26898966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington study group's neuropsychology working group position on best practice recommendations for the clinical neuropsychological evaluation of patients with Huntington disease.
    Considine CM; Rossetti MA; Anderson K; Del Bene VA; Anderson SA; Celka AS; Edmondson MC; Sheese ALN; Piccolino A; Teixeira AL; Stout JC
    Clin Neuropsychol; 2024 May; 38(4):984-1006. PubMed ID: 37849335
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuropsychiatric symptoms in South-East Asian patients with mild cognitive impairment and dementia: prevalence, subtypes, and risk factors.
    Yatawara C; Hiu S; Tan L; Kandiah N
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):122-130. PubMed ID: 28239920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.
    Lyketsos CG; Lopez O; Jones B; Fitzpatrick AL; Breitner J; DeKosky S
    JAMA; 2002 Sep; 288(12):1475-83. PubMed ID: 12243634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.
    Devlin JW; Skrobik Y; Gélinas C; Needham DM; Slooter AJC; Pandharipande PP; Watson PL; Weinhouse GL; Nunnally ME; Rochwerg B; Balas MC; van den Boogaard M; Bosma KJ; Brummel NE; Chanques G; Denehy L; Drouot X; Fraser GL; Harris JE; Joffe AM; Kho ME; Kress JP; Lanphere JA; McKinley S; Neufeld KJ; Pisani MA; Payen JF; Pun BT; Puntillo KA; Riker RR; Robinson BRH; Shehabi Y; Szumita PM; Winkelman C; Centofanti JE; Price C; Nikayin S; Misak CJ; Flood PD; Kiedrowski K; Alhazzani W
    Crit Care Med; 2018 Sep; 46(9):e825-e873. PubMed ID: 30113379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial or clinico-demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE-AD study.
    Nagata T; Nakajima S; Shinagawa S; Plitman E; Graff-Guerrero A; Mimura M; Nakayama K
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):1264-1271. PubMed ID: 27714849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of neuropsychiatric syndromes with global clinical deterioration in Alzheimer's disease patients.
    Stella F; Laks J; Govone JS; de Medeiros K; Forlenza OV
    Int Psychogeriatr; 2016 May; 28(5):779-86. PubMed ID: 26673910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit.
    Barr J; Fraser GL; Puntillo K; Ely EW; Gélinas C; Dasta JF; Davidson JE; Devlin JW; Kress JP; Joffe AM; Coursin DB; Herr DL; Tung A; Robinson BR; Fontaine DK; Ramsay MA; Riker RR; Sessler CN; Pun B; Skrobik Y; Jaeschke R;
    Crit Care Med; 2013 Jan; 41(1):263-306. PubMed ID: 23269131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The course of neuropsychiatric symptoms in nursing-home patients with dementia over a 53-month follow-up period.
    Selbaek G; Engedal K; Benth JŠ; Bergh S
    Int Psychogeriatr; 2014 Jan; 26(1):81-91. PubMed ID: 24059840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders.
    Kulisevsky J; Litvan I; Berthier ML; Pascual-Sedano B; Paulsen JS; Cummings JL
    Mov Disord; 2001 Nov; 16(6):1098-104. PubMed ID: 11748741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the management of neuropsychiatric symptoms in dementia.
    Forlenza OV; Loureiro JC; Pais MV; Stella F
    Curr Opin Psychiatry; 2017 Mar; 30(2):151-158. PubMed ID: 28079675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodologic Innovation in Creating Clinical Practice Guidelines: Insights From the 2018 Society of Critical Care Medicine Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption Guideline Effort.
    Devlin JW; Skrobik Y; Rochwerg B; Nunnally ME; Needham DM; Gelinas C; Pandharipande PP; Slooter AJC; Watson PL; Weinhouse GL; Kho ME; Centofanti J; Price C; Harmon L; Misak CJ; Flood PD; Alhazzani W
    Crit Care Med; 2018 Sep; 46(9):1457-1463. PubMed ID: 29985807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus.
    Kales HC; Lyketsos CG; Miller EM; Ballard C
    Int Psychogeriatr; 2019 Jan; 31(1):83-90. PubMed ID: 30068400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.